Clinigen shares fall 25% on profit warning
Shares in global products and pharmaceutical services company Clinigen (CLIN:AIM) sank 25% to 626p after warning that profits will be lower than guided as Covid-19 continued to impact hospital-based cancer treatments and delayed...
09 June 2021